Canadian application, no grantCanada
Genetically-modified fibroblasts and the use thereof
CA 2331826 A1 · Owner: Genera S.P.A. · Inventors: Mavilio, Fulvio
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for the preparation of genetically-modified fibroblasts expressing a muscle lineage commitment gene, and the use thereof for the treatment of genetic defects or for the expression of therapeutic proteins.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 5, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 5, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 5, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 5, 1999
GrantedNo grant recorded
Term endedMay 5, 2019
Patent numberCA 2331826 A1
Classification (IPC)C12N5/10 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.